Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00226408
What this trial is testing

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Who this might be right for
AdjuvantStage III Malignant MelanomaInterferon Alpha+1 more
Dermatologic Cooperative Oncology Group 600
Not applicableLooking for participantsNCT07050940
What this trial is testing

Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study

Who this might be right for
Melanoma Metastatic
Azienda Ospedaliera di Perugia 35
Testing effectiveness (Phase 2)Study completedNCT00261365
What this trial is testing

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Who this might be right for
Unresectable Stage III or IV Malignant Melanoma
Bristol-Myers Squibb 80
Very early researchStudy completedNCT02320305
What this trial is testing

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Stage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more
Mayo Clinic 23
Testing effectiveness (Phase 2)UnknownNCT00086866
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 165
Testing effectiveness (Phase 2)Ended earlyNCT02414750
What this trial is testing

Vemurafenib Plus Cobimetinib in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Netherlands Working Group on Immunotherapy of Oncology 78
Early research (Phase 1)Ended earlyNCT05393713
What this trial is testing

Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8MelanomaMetastatic Melanoma+1 more
Mayo Clinic 3
Early research (Phase 1)WithdrawnNCT00661336
What this trial is testing

A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Duke University
Large-scale testing (Phase 3)Ended earlyNCT01546571
What this trial is testing

Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients

Who this might be right for
Melanoma
Polynoma LLC 504
Testing effectiveness (Phase 2)UnknownNCT03190824
What this trial is testing

Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage Iv
Syneos Health 4
Testing effectiveness (Phase 2)Study completedNCT01950390
What this trial is testing

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Stage IIIC Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7Unresectable Melanoma
National Cancer Institute (NCI) 169
Testing effectiveness (Phase 2)Ended earlyNCT02718391
What this trial is testing

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.

Who this might be right for
Malignant MelanomaAdjuvant Drug TherapyVaccin Therapy
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06500455
What this trial is testing

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Digestive System Carcinoma+7 more
NRG Oncology 274
Testing effectiveness (Phase 2)Ended earlyNCT03325101
What this trial is testing

Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+2 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00028431
What this trial is testing

Novel Adjuvants for Peptide-Based Melanoma Vaccines

Who this might be right for
Melanoma
University of Southern California 19
Testing effectiveness (Phase 2)Looking for participantsNCT05251389
What this trial is testing

FMT to Convert Response to Immunotherapy

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT00016263
What this trial is testing

Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Genta Incorporated
Testing effectiveness (Phase 2)UnknownNCT02977052
What this trial is testing

Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 186
Testing effectiveness (Phase 2)Ended earlyNCT01316692
What this trial is testing

Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIc MelanomaStage IV Melanoma
Vanderbilt-Ingram Cancer Center 12
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Next Page